Alnylam Pharmaceuticals, Inc.
$244.15
$4.59(1.92%)
ALNY
Alnylam Pharmaceuticals, Inc.
$244.15
1D:
1.9%
1Y:
-46.8%
US02043Q1076Healthcare
Chart
Key stats
52-Week Range$244.15
$197.81
$495.55
Market capitalization
$32.06BDividend yield (indicated)
0.00%Price to earnings Ratio (TTM)
39.27Basic EPS (TTM)
$6.10Net income (TTM)
$807.99MRevenue (TTM)
$4.80BAvg. volume
1.62MBeta (1Y)
0.30Employees
2.50KMarket capitalization
$32.06BDividend yield (indicated)
0.00%Price to earnings Ratio (TTM)
39.27Basic EPS (TTM)
$6.10Net income (TTM)
$807.99MRevenue (TTM)
$4.80BAvg. volume
1.62MBeta (1Y)
0.30Employees
2.50KScreener Quick Check
Sign in to check this stock against your screeners
Sign InRelated Stocks
$784.85
1D:
-0.6%
1Y:
31.1%
US75886F1075Healthcare
Mkt Cap
$80.86B
P/E Ratio TTM
18.7
Revenue TTM
$15.53B
Beta
0.24
Earnings TTM
$4.33B
Dividend Yield TTM
0.47%
$275.28
1D:
-0.3%
1Y:
-6.3%
US1255231003Healthcare
Mkt Cap
$72.74B
P/E Ratio TTM
11.4
Revenue TTM
$282.38B
Beta
0.32
Earnings TTM
$6.42B
Dividend Yield TTM
2.25%